• Shohet Ear Associates
    446 Old Newport Blvd. Suite 100
    Newport Beach, California 92663

    To Schedule An Ear Appointment, Please Call:

    (949) 631-HEAR
    949-631-4327
    Home
    New - Envoy Esteem
    Our Services
    Medical Services
    Audiology Services
    Pediatric Services
    Conditions & Treatments
    About the Ear
    Hearing Loss
    Implantable Hearing Technology
    Otosclerosis
    Vertigo & Balance Disorders
    Kids & Hearing Disorders
    Aural Atresia
    Tinnitus
    Hyperacusis
    Ear Infections
    Cholesteatoma
    Surfer's Ear
    Facial Nerve Disorders
    Ear and Skull Base Tumors
    Hearing Aids
    Hearing Loss
    Hearing Aids and Hearing Loss
    Do You Need A Hearing Test?
    Looking For A Hearing Aid?
    Hearing Aid Styles
    Hearing Aid Technology
    Assisted Listening Devices
    About Us
    Bios / Credentials
    Philosophy of Care
    Office Location
    Contact Us
    Contact Us
    Office Location
    Request A Speaker
    Upcoming Events
    What our Patients Say
    Patient Testimonials
    Patient Satisfaction Stats
    For Patients
    General Office Policies
    Downloadable Forms
    Financial Arrangements
    Medications Prescribed
    Before Your Procedure
    Medications To Avoid Before Surgery
    Post-operative Instructions
    Privacy Statement
    Patient Satisfaction
    Take our Survey
    News
    Press Releases
    Articles / Abstracts
    Upcoming Events
    Dr. Shohet in the Media
    Videos
    Links & Resources
    Email Newsletter Sign-Up
    Make An Appointment
    Read our Blog

    Dr. Joni Doherty has been listed in the 2009/2010 edition of "Best Doctors."




    Subscribe to our Blog


    Dr. Shohet on YouTube


    Dr. Shohet on Facebook

    SEARCH THIS SITE:
    DATE: July 31, 2010    TIME: 3:23 PM

    Neuromonics

    What You Should Know

    About Neuromonics Tinnitus Treatment

    The Neuromonics Tinnitus Treatment is an FDA-cleared, non-invasive approach that may provide a significant long-term reduction in tinnitus disturbance. Tinnitus can be a debilitating condition often characterized by a constant ringing in the ears. The treatment is designed to interact, interrupt and desensitize tinnitus disturbance, changing how the brain perceives the tinnitus sounds. It is the most comprehensive long-term therapy that targets the audiological, neurological and psychological basis of the condition.

    The Neuromonics Tinnitus Treatment is delivered via a compact, lightweight and specially-designed medical device. Using a highly sophisticated and patented algorithm, the Neuromonics Tinnitus Treatment is customized to the individual patient’s unique hearing and tinnitus profile. It sends particular auditory stimulation across a broad range of frequencies, including high frequencies most critical for tinnitus treatment. The Neuromonics Tinnitus Treatment introduces and delivers both continuous and intermittent pre-programmed stimuli, which is coordinated with precisely-designed music.

    The stimulus targets the brain’s auditory pathways and aids in neuroplasticity, or establishing new neural connections. The Neuromonics Tinnitus Treatment leverages recent scientific findings that the brain is not hard-wired with fixed neurological circuits. By enabling new neural connections, the Neuromonics Tinnitus Treatment helps sufferers filter out the tinnitus sound for long-term benefit. Additionally, the music engages the brain’s limbic system, the part of the brain associated with emotional response, allowing for effective stimulus delivery and treatment.

    Prior to treatment, the patient’s tinnitus and hearing is evaluated to determine his or her personal audiological profile. If the patient is an appropriate candidate, delivery and fitting of the customized Neuromonics device takes place with the physician or audiologist.

    Treatment occurs over a six-month period and is administered by an audiologist or physician. It involves two stages:

    • Stage One: treatment offers relief from tinnitus symptoms, by delivering an acoustic neural stimulus that provides a high level of interaction with tinnitus perception. The stage lasts approximately two months.
    • Stage Two: the acoustic neural stimulus changes to deliver an intermittent or lower level of interaction with the patient’s tinnitus perception. This allows desensitization to occur. The stage lasts approximately four months.

    About Neuromonics

    Neuromonics is the manufacturer and distributor of the only FDA-cleared, patented, customized and clinically-proven medical device designed for long-term significant relief of tinnitus. With more than fourteen years of research and development, the Neuromonics Tinnitus Treatment has treated thousands of tinnitus sufferers worldwide. The goal of Neuromonics is to help tinnitus sufferers improve their quality of life and overcome challenges associated with tinnitus.

    Founded in 2001, Neuromonics developed a breakthrough medical device for the treatment of tinnitus. The Neuromonics Tinnitus Treatment was discovered and developed at Western Australia’s Curtin University of Technology by Dr. Paul Davis. The uniquely patented device and the associated treatment has been through extensive refinement through ongoing research and multiple clinical trials. The product, originally launched in Australia in 2004, has shown widespread acceptance and validation with thousands of patients having completed treatment. In late 2005, the product was launched in a few select clinics in the United States. With continued validation of the effectiveness of the treatment, business in the United States has seen rapid growth with expansion plans in the next few years to include both Europe and Asia.

    Clinical Outcomes
    (after 6 months of treatment*):

    • 40% + Reduction in Tinnitus Disturbance**………………….…95%
    • 40% + Reduction in Tinnitus Awareness…………….…………84%
    • 5dB + Reduction in Minimum Masking Level***……………..…78%
    • 5dB + Improvement in Loudness Discomfort Levels****…..….69%

    *Clinical measures reported by participants with significant levels of tinnitus disturbance prior to treatment.
    **Measured by the Tinnitus Reaction Questionnaire
    ***Participants with pretreatment minimum masking level of greater than 5dB
    ****Participants with decreased sound tolerance

    Patient Satisfaction

    • Relief from Tinnitus ……………………..……….97%
    • Improved ability to fall Asleep …………......….…94%
    • A Sense of Control of Tinnitus ……….........…….94%
    • Improved ability to Relax ……………..…...…….94%

    Davis, P., Paki, B., Hanley, P. Neuromonics Tinnitus Treatment: Third Clinical Trial. Ear and Hearing. 2007; Vol. 28, No. 2; 242-257.


     


    Any information provided on this web site should not be considered medical advice or a substitute for a consultation
    with a physician. If you have a medical problem, contact your physician for an evaluation.
    Privacy - Contact Us - Links - Medical Articles
    Copyright © 2010 Shohet Ear Associates Medical Group, Inc. All Rights Reserved. Duplication of any part of this website is prohibited.